IL10 and inflammatory bowel disease: Given that CD is strongly associated with full-thickness damage of the small intestine, resulting in fibrosis and restructuring, targeting IL-10 could be a potential therapeutic approach to prevent the development of fibrosis in intestinal tissue in IBD.